2019, Number 2
Microalbuminuria as a marker of kidney damage in patients with arterial hypertension
Language: Spanish
References: 24
Page: 217-230
PDF size: 660.54 Kb.
ABSTRACT
Introduction: Arterial hypertension is a powerful risk factor for kidney damage. The prevalence is very high among patients with chronic kidney disease.Objective: To determine the presence of microalbuminuria as a marker of kidney damage in patients with arterial hypertension admitted between September 2016 and September 2017.
Material and Methods: A descriptive, longitudinal, prospective study was conducted in 123 patients. Age; sex; cholesterol, triglycerides, creatinine and microalbuminuria levels and vascular risk factors were determined. Descriptive and inferential statistics were used.
Results: The 40.7% of patients belong to the group of patients of age more than 70 years, predominating the male sex (65%); 62.6% of them presented microalbuminuria and 97.3% had risk factors associated with an increased prevalence of smoking, dyslipidemia, obesity, and vascular diseases associated with RP> 1. The group of patients older than 70 years, male, and with presence of microalbuminuria predominated in the study. The presence of more than three risk factors was associated with microalbuminuria. The presence of microalbuminuria increased with the years of evolution of the disease. Stage 3 of chronic kidney disease predominated in patients with arterial hypertension and microalbuminuria and it was directly related to the years of evolution of arterial hypertension.
Conclusions: The determination of microalbuminuria in patients with arterial hypertension is a simple and important risk marker to determine subclinical kidney damage and it is closely related to the increase in the age of the patient, the years of hypertension, and the association with other risk factors for vascular disease.
REFERENCES
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA [Internet]. 2014; 311(5):507-20. [Cited 2018 Dic 16]. Available from: https://jamanetwork.com/journals/jama/fullarti cle/1791497
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC. Guidelines for the management of arterial hypertension: The task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens [Internet]. 2013; 31(7):1281-357. [ Cited 2018 Dic 16]. Available from: https://journals.lww.com/jhypertension/Fulltext /2013/10000/2013_Practice_guidelines_for_the _management_of.2.aspx
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. [Internet]. 2015;129(3):e28-e292. [Cited 2018 Dic 16]. Available from: https://www.scholars.northwestern.edu/en/pub lications/heart-disease-and-stroke-statistics- 2016-update-a-report-from-the
Stevens PE, Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. [Internet].2013;158(11):825-30. [Cited 2018 Dic 16]. Available from: http://annals.org/aim/fullarticle/1691737
Castillo Álvarez Y, Chávez Vega R, Alfonzo Guerra JP. Incidence and prevalence of high blood pressure registered in the World Day of the Fight Against the High Blood Pressure. A working group experience. Rev cubana med [Internet]. 2011 Sep; 50( 3 ): 234-241. [ Cited 2018 Dic 16]. Available from http://scielo.sld.cu/scielo.php?script=sci_arttext &pid=S0034-75232011000300002&lng=es
Micht WE. Enfermedad renal cronica. En: Goldman L, Schafer AI, editores. Goldman-Cecil. Tratado de medicina interna + ExpertConsult [Internet]. 25ta ed. Barcelona, España: Elsevier España, S.L.U.; 2017. [Citado 25 May 2017]. Disponible en: https://www.clinicalkey.es/#!/content/book/3- s2.0-B9788491130338004079
D´Achiardi Rey R, Vargas J, Echeverri J, Moreno M, Quiroz G. Factores de riesgo de en enfermedad renal crónica. Rev fac med [serial on the Internet]. 2011; 19(2): [aprox. 0 p.]. [Citado 22 noviembre 2017]. Disponible en: http://www.scielo.org.co/pdf/med/v19n2/v19n 2a09&rct=j&q=&esrc=s&sa=U&ved=0ahUKEwjFq NqonpHNAhUIbj4KHRfWDiMQFggTMAA&sig2=y ZTcxQ6gTrwbhJpxltmGBg&usg=AFQjCNHRacqpw LEgh95jLE1VumOvyxmcBg
Terazón Miclín O, Vinent Terazón MA, Pouyou Semanat J. Determinación del grado de enfermedad renal crónica en pacientes hipertensos. MEDISAN [Internet]. 2017 Ene; 21(1): 19-26. [Citado 2018 Sep 23]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_ arttext&pid=S102930192017000100003&lng=es
Díaz Gómez JL, Landell Cruz J, Lazo Sánchez Y, Argote Viñals C. Comportamiento de la insuficiencia renal crónica terminal en el Servicio de Nefrología de Las Tunas. Rev Electrón Dr. Zoilo E. Marinello Vidaurreta [Internet]. 2005; 29(May-Ago.): [aprox. 6 p.]. [Citado 12 May 2018]. Disponible en: http://www.ltu.sld.cu/revistam/index_files/artic les/mayo-agosto2005_5.htm
Poll Pineda JA, Rueda Macías NM, Poll Rueda A, Mancebo Villalón A, Arias Moncada L. Factores de riesgo asociados a la Enfermedad Renal Crónica en adultos mayores. MEDISAN [revista en Internet] 2017; 21 (9): 2034- 2041.[Citado 2018 Sep 17]. Disponible en: http://www.redalyc.org/articulo.oa?id=3684526 84006
León Álvarez JL, García Sánchez N, Gutiérrez Rojas A, Pérez Caballero MD. Biomarcadores de daño renal en la hipertensión arterial esencial. Rev cubana med [Internet]. 2016 Dic; 55(4): 297-310. [Citado 2018 Sep 22]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext &pid=S003475232016000400004&lng=es
Neira Urrutia C, Oliva Mella P, Osses Paredes C. Función renal y factores asociados en el desarrollo de la Enfermedad Renal Crónica en adultos. Rev Cubana Enfermer [Internet]. 2014 Dic; 30(4). [aprox. 0 p.]. [Citado 2018 Sep 23]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext &pid=S0864-03192014000400004&lng=es
Benozzi S, Pennacchiotti GL. Detección temprana de la Enfermedad Renal Crónica: una tarea conjunta entre médicos y bioquímicos. Archivos de Medicina Familiar y Genera [Internet] 2015; 12(1): 19-29. [Citado 2018 Sep 22]. Disponible en: http://revista.famfyg.com.ar/index.php/AMFG/a rticle/download/64/56
Hickman Álvarez A, López Campos C. Prevalencia y factores de riesgo de Enfermedad Renal Crónica en pacientes hipertensos y diabéticos de dos comunidades rurales. Desafíos. [Internet]. 2015;9(2) 40-51. [Citado 2018 Sep 22]. Disponible en: http://revistas.ut.edu.co/index.php/desafios/art icle/viewFile/753/588
Bardelli Guibovich ML, Castillo Campos R, Medina Sánchez C. Microalbuminuria y factores de riesgo cardiovascular en hipertensos: resultados de Perú del estudio global I SEARCH. Rev Soc Peru Med Interna. [Internet]. 2012; 25(1):11-17. [Citado 2018 Nov 16]. Disponible en: http://www.medicinainterna.org.pe/revista/revi sta_25_1_2012/rev_spmi_2012_1_trabajo_origi nal_2.pdf
Figueroa-Montes LE, Ramos-García MY. Diagnóstico de albuminuria en pacientes mayores de 55 años en una red asistencial. Acta méd. peruana [Internet]. 2014 Ene; 31(1): 7-14. [ Citado 2018 Nov 16]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_ arttext&pid=S1728- 59172014000100003&lng=es
Otero González A, De Francisco ALM, Gayoso P, Garcia López F. Obesidad y funcion renal Datos del estudio epidemiológico: Prevalencia de la Enfermedad Renal Cronica en España. Estudio EPIRCE. Nefrología (Madr.) [Internet]. 2018 Feb; 38(1): 107-108. [Citado 2018 Sep 23]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttex t&pid=S021169952018000100107&lng=es
Blanch P. Freixa Pamias R. Estrategia óptima de búsqueda de daño de órgano diana asintomático en el hipertenso. Hipertensión y Riesgo Vascular [Internet] Octubre–Diciembre 2017; 34 (4): 145-148. [Citado 2018 Nov 16]. Disponible en: https://www.sciencedirect.com/science/article/ abs/pii/S1889183717300788
Poveda MI, García del Pino D, Pino R, Alarcón Rodríguez C, Rodelo H, Parrón Carreño T. El valor de la MAPA y de los parámetros de lesión subclínica de órgano diana en el diagnóstico de hipertensión refractaria. Nefrología [Internet]; 2018; 39 (1): 67-72. [Citado 2018 Sept 22]. Disponible en: https://www.revistanefrologia.com/es-el-valormapa- los-parametros-articulo- S0211699518300717
Díaz MP, Sanjurjo SC, Caro JL, Carratala VP, Garcia JP, Vargas MF, et al. Microalbuminuria and cardiovascular disease in hypertensive patients included in the iberican study. Journal of Hypertension. [Internet]. 2018; 36: e184. [Citado 2018 Sep 22]. Available from: https://journals.lww.com/jhypertension/Abstrac t/2018/06001/MICROALBUMINURIA_AND_CAR DIOVASCULAR_DISEASE_IN.552.aspx